Aardvark Therapeutics, Inc.
Clinical trials sponsored by Aardvark Therapeutics, Inc., explained in plain language.
-
New drug trial aims to tame uncontrollable hunger in rare genetic disorder
Disease control TerminatedThis study is testing whether ARD-101 can safely help control the extreme, life-threatening hunger experienced by people with Prader-Willi syndrome over a full year. It follows 90 patients who previously participated in a related 12-week trial, asking them to take the medication …
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug trial aims to tame uncontrollable hunger in rare genetic disorder
Symptom relief TerminatedThis study is testing whether an investigational drug called ARD-101 can reduce the extreme, life-threatening hunger (hyperphagia) experienced by people with Prader-Willi syndrome. About 90 participants, aged 7 and older, will take either ARD-101 or a placebo pill daily for 12 we…
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC